Tierarztl Prax Ausg K Kleintiere Heimtiere 2021; 49(05): 349-356
DOI: 10.1055/a-1584-4965
Original Article

Clinical relevance of intradermal test results in atopic dogs

Klinische Relevanz von Intrakutantest-Ergebnissen bei atopischen Hunden
Stefanie Mallmann
1   Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany, present address: Finidore Manufaktur, Greifenberg, Germany
,
Christoph J. Klinger
2   Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany, present address: Tierklinik Stuttgart-Plieningen, Germany
,
Janine Claßen
3   Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany, present address: Small Animal Clinic, Oberhaching, Germany
,
Iris Wagner
4   Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany
,
Andre Klima
5   Statistical consulting unit StaBLab, Department of Statistics, LMU Munich, Germany
,
Noemi Castelletti
5   Statistical consulting unit StaBLab, Department of Statistics, LMU Munich, Germany
,
Ralf S. Müller
4   Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany
› Author Affiliations

Abstract

Topic and aims Canine atopic dermatitis (AD) is an inflammatory and pruritic skin disease and in most cases associated with IgE antibodies against environmental allergens. To date, the only causative therapeutic option is allergen immunotherapy (AIT). Offending allergens for AIT can be identified by intradermal testing (IDT) or serum allergen-specific IgE testing. The aim of the study was to evaluate positive IDT results considering the atopic dogs’ clinical history.

Material and methods An IDT was performed on 48 atopic dogs and their owners completed a detailed questionnaire about the seasonal course of their pruritus. Results of IDT were correlated with the seasonal occurrence of pruritus.

Results The most common positive IDT reactions were observed to mite allergens (33.3–62.5 %). Prevalence of positive reactions to individual tree, grass and weed pollen ranged between 8.3 % and 25 %. Moulds and epithelial allergens produced positive reactions in only 0–6.3 %. A correlation between positive IDT reactions and course of pruritus could neither be found for perennial nor for seasonal allergens.

Conclusion The evaluation of IDT reactions may not be an optimal method for identification of clinically relevant allergens in canine AD.

Clinical relevance The results of this study emphasise the importance of considering clinical history in addition to allergy test results in the formulation of an allergen extract for desensitisation.

Zusammenfassung

Gegenstand und Ziel Die kanine atopische Dermatitis (AD) ist eine entzündliche und juckende Hautkrankheit, bei der in den meisten Fällen IgE-Antikörper gegen Umweltallergene auftreten. Bis heute stellt die Allergen-Immuntherapie (AIT) die einzige kausale Therapie dar. Am Krankheitsgeschehen beteiligte Allergene können durch Intrakutantests (IKT) oder Serumtests auf allergenspezifisches IgE identifiziert werden. Ziel dieser Studie war herauszufinden, ob positive IKT-Ergebnisse mit der Anamnese der atopischen Hunde korrelieren.

Material und Methoden Bei 48 atopischen Hunden, bei denen ein IKT durchgeführt wurde, füllten die Hundebesitzer einen detaillierten Fragebogen über den jahreszeitlichen Verlauf des Juckreizes ihrer Hunde aus. Die Antworten in den Fragebögen wurden in Beziehung zu den Resultaten des IKT gesetzt.

Ergebnisse Die häufigsten positiven Reaktionen wurden gegen Hausstaubmilben festgestellt (33,3–62,5 %). Die Prävalenz positiver Resultate gegen die getesteten Pollen von Bäumen, Gräsern und Kräutern lag zwischen 8,3 % und 25 %. Schimmelpilze und Epithelien führten bei 0–6,3 % zu positiven Reaktionen. Positive IKT-Ergebnisse gegen ganzjährige und saisonale Allergene korrelierten nicht mit dem Auftreten von Juckreiz.

Schlussfolgerung Die Bewertung von Reaktionen im IKT ist möglicherweise nicht die optimale Methode für die Bestimmung der klinisch relevanten Allergene bei kaniner AD.

Klinische Relevanz Die Ergebnisse dieser Studie bestätigen, dass bei der Auswahl von Allergenen für die AIT die klinische Anamnese zusätzlich zu den Ergebnissen des Allergietests berücksichtigt werden muss.



Publication History

Received: 06 December 2020

Accepted: 16 February 2021

Article published online:
20 October 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Olivry T, DeBoer DJ, Griffin CE. et al. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Vet Immunol Immunopathol 2001; 81: 143-146 S0165242701003439 [pii]
  • 2 Marsella R, Sousa CA, Gonzales AJ. et al. Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis. J Am Vet Med Assoc 2012; 241: 194-207
  • 3 Pucheu-Haston CM, Bizikova P, Eisenschenk MN. et al. Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis. Vet Dermatol 2015; 26: 115-e130
  • 4 Pucheu-Haston CM, Bizikova P, Marsella R. et al. Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis. Vet Dermatol 2015; 26: 124-e132
  • 5 Hensel P, Santoro D, Favrot C. et al. Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Vet Res 2015; 11: 196
  • 6 Olivry T, DeBoer DJ, Favrot C. et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet Res 2015; 11: 210
  • 7 Olivry T, Foster AP, Mueller RS. et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010; 21: 4-22
  • 8 Loewenstein C, Mueller RS. A review of allergen-specific immunotherapy in human and veterinary medicine. Vet Dermatol 2009; 20: 84-98
  • 9 Mueller RS, Jensen-Jarolim E, Roth-Walter F. et al. Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs. Allergy 2018; 73: 1989-1999
  • 10 Hillier A, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XVII): intradermal testing. Vet Immunol Immunopathol 2001; 81: 289-304
  • 11 Bizikova P, Santoro D, Marsella R. et al. Review: Clinical and histological manifestations of canine atopic dermatitis. Vet Dermatol 2015; 26: 79-e24
  • 12 Favrot C, Steffan J, Seewald W. et al. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 23-31
  • 13 Mueller RS, Bettenay SV, Tideman L. Aero-allergens in canine atopic dermatitis in southeastern Australia based on 1000 intradermal skin tests. Aust Vet J 2000; 78: 392-399
  • 14 Nesbitt GH. Canine allergic inhalant dermatitis: a review of 230 cases. J Am Vet Med Assoc 1978; 172: 55-60
  • 15 Saridomichelakis MN, Koutinas AF, Gioulekas D. et al. Canine atopic dermatitis in Greece: clinical observations and the prevalence of positive intradermal test reactions in 91 spontaneous cases. Vet Immunol Immunopathol 1999; 69: 61-73
  • 16 Farmaki R, Saridomichelakis MN, Leontides L. et al. Dust mite species in the households of mite-sensitive dogs with atopic dermatitis. Vet Dermatol 2012; 23: 222-e245
  • 17 Henneveld K, Beck W, Mueller RS. Evaluierung von Vorratsmilben in kommerziellem Hundetrockenfutter und in der Umgebung sowie ihre Bedeutung in der Tiermedizin. Tierarztl Prax Ausg K Kleintiere Heimtiere 2007; 35 (05) 325-332
  • 18 Saridomichelakis MN, Marsella R, Lee KW. et al. Assessment of cross-reactivity among five species of house dust and storage mites. Vet Dermatol 2008; 19: 67-76
  • 19 Elholm G, Linneberg A, Husemoen LL. et al. The Danish urban-rural gradient of allergic sensitization and disease in adults. Clin Exp Allergy 2016; 46: 103-111
  • 20 Hensel P, Austel M, Medleau L. et al. Determination of threshold concentrations of allergens and evaluation of two different histamine concentrations in canine intradermal testing. Vet Dermatol 2004; 15: 304-308
  • 21 Mueller RS. Intradermale Reaktionen gegen die Vorratsmilbe Lepidoglyphus destructor bei normalen Hunden und Hunden mit atopischer Dermatitis. Kleintierprax 2011; 56: 5-10
  • 22 Gedon NKY, Boehm T, Klinger CJ. et al. Agreement of serum allergen test results with unblocked and blocked IgE against cross-reactive carbohydrate determinants (CCD) and intradermal test results in atopic dogs. Vet Dermatol 2019; 30: 195-e161
  • 23 Rodrigues DF, Goulart EM. Patch-test results in children and adolescents: systematic review of a 15-year period. An Bras Dermatol 2016; 91: 64-72
  • 24 Marsella R, Nicklin C, Lopez J. Atopy patch test reactions in high-IgE beagles to different sources and concentrations of house dust mites. Vet Dermatol 2005; 16: 308-314
  • 25 Olivry T, Deangelo KB, Dunston SM. et al. Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis. Vet Dermatol 2006; 17: 95-102
  • 26 Bauer CL, Hensel P, Austel M. et al. Determination of irritant threshold concentrations to weeds, trees and grasses through serial dilutions in intradermal testing on healthy clinically nonallergic dogs. Vet Dermatol 2010; 21: 192-197
  • 27 Picco F, Zini E, Nett C. et al. A prospective study on canine atopic dermatitis and food-induced allergic dermatitis in Switzerland. Vet Dermatol 2008; 19: 150-155
  • 28 Plant JD, Neradilek MB. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis. BMC Vet Res 2017; 13: 4
  • 29 Wagner I, Geh KJ, Hubert M. et al. Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis. Vet Rec 2017; 181 (05) 100-124
  • 30 Mueller RS, Olivry T. Critically appraised topic on adverse food reactions of companion animals (4): can we diagnose adverse food reactions in dogs and cats with in vivo or in vitro tests?. BMC Vet Res 2017; 13: 275
  • 31 Foster AP, Jackson HA, Stedman K. et al. Serological responses to house dust mite antigens in atopic dogs while receiving allergen-specific immunotherapy. Vet Dermatol 2002; 13: 211-229